482 related articles for article (PubMed ID: 30657529)
1. Association of Pharmaceutical Industry Marketing of Opioid Products With Mortality From Opioid-Related Overdoses.
Hadland SE; Rivera-Aguirre A; Marshall BDL; Cerdá M
JAMA Netw Open; 2019 Jan; 2(1):e186007. PubMed ID: 30657529
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Rural vs Urban Direct-to-Physician Commercial Promotion of Medications for Treating Opioid Use Disorder.
Nguyen T; Andraka-Christou B; Simon K; Bradford WD
JAMA Netw Open; 2019 Dec; 2(12):e1916520. PubMed ID: 31790568
[TBL] [Abstract][Full Text] [Related]
3. Industry Payments to Physicians for Opioid Products, 2013-2015.
Hadland SE; Krieger MS; Marshall BDL
Am J Public Health; 2017 Sep; 107(9):1493-1495. PubMed ID: 28787210
[TBL] [Abstract][Full Text] [Related]
4. Association of Medicaid Expansion With Opioid Overdose Mortality in the United States.
Kravitz-Wirtz N; Davis CS; Ponicki WR; Rivera-Aguirre A; Marshall BDL; Martins SS; Cerdá M
JAMA Netw Open; 2020 Jan; 3(1):e1919066. PubMed ID: 31922561
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical payments to physicians may increase prescribing for opioids.
Nguyen TD; Bradford WD; Simon KI
Addiction; 2019 Jun; 114(6):1051-1059. PubMed ID: 30667135
[TBL] [Abstract][Full Text] [Related]
6. Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015.
Guy GP; Zhang K; Bohm MK; Losby J; Lewis B; Young R; Murphy LB; Dowell D
MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(26):697-704. PubMed ID: 28683056
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder.
Haffajee RL; Lin LA; Bohnert ASB; Goldstick JE
JAMA Netw Open; 2019 Jun; 2(6):e196373. PubMed ID: 31251376
[TBL] [Abstract][Full Text] [Related]
8. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
[TBL] [Abstract][Full Text] [Related]
9. Association between industry payments for opioid products and physicians' prescription of opioids: observational study with propensity-score matching.
Inoue K; Figueroa JF; Orav EJ; Tsugawa Y
J Epidemiol Community Health; 2020 Aug; 74(8):647-654. PubMed ID: 32350126
[TBL] [Abstract][Full Text] [Related]
10. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
11. Association Between Automotive Assembly Plant Closures and Opioid Overdose Mortality in the United States: A Difference-in-Differences Analysis.
Venkataramani AS; Bair EF; O'Brien RL; Tsai AC
JAMA Intern Med; 2020 Feb; 180(2):254-262. PubMed ID: 31886844
[TBL] [Abstract][Full Text] [Related]
12. Provider-directed marketing may increase prescribing of medications for opioid use disorder.
Nguyen T; Andraka-Christou B; Simon K; Bradford WD
J Subst Abuse Treat; 2019 Sep; 104():104-115. PubMed ID: 31370974
[TBL] [Abstract][Full Text] [Related]
13. Association of Pharmaceutical Manufacturer Payments to Physicians and Prescribing Dosage of Opioids.
Fleischman W; Agrawal S; Gross CP; Ross JS
J Gen Intern Med; 2019 Jul; 34(7):1074-1076. PubMed ID: 31011967
[No Abstract] [Full Text] [Related]
14. Payments from drug companies to physicians are associated with higher volume and more expensive opioid analgesic prescribing.
Zezza MA; Bachhuber MA
PLoS One; 2018; 13(12):e0209383. PubMed ID: 30566426
[TBL] [Abstract][Full Text] [Related]
15. Effect of reductions in opioid prescribing on opioid use disorder and fatal overdose in the United States: a dynamic Markov model.
Alexander GC; Ballreich J; Mansour O; Dowdy DW
Addiction; 2022 Apr; 117(4):969-976. PubMed ID: 34590369
[TBL] [Abstract][Full Text] [Related]
16. As opioid overdose deaths reach record highs, call for systematic changes grows louder.
ED Manag; 2016 Feb; 28(2):13-9. PubMed ID: 26939351
[TBL] [Abstract][Full Text] [Related]
17. Opioid Prescribing Patterns Before Fatal Opioid Overdose.
Abbasi AB; Salisbury-Afshar E; Berberet CE; Layden JE; Pho MT
Am J Prev Med; 2020 Feb; 58(2):250-253. PubMed ID: 31959322
[TBL] [Abstract][Full Text] [Related]
18. Opioid Prescribing Rates in Nonmetropolitan and Metropolitan Counties Among Primary Care Providers Using an Electronic Health Record System - United States, 2014-2017.
García MC; Heilig CM; Lee SH; Faul M; Guy G; Iademarco MF; Hempstead K; Raymond D; Gray J
MMWR Morb Mortal Wkly Rep; 2019 Jan; 68(2):25-30. PubMed ID: 30653483
[TBL] [Abstract][Full Text] [Related]
19. Physician Prescribing of Opioids to Patients at Increased Risk of Overdose From Benzodiazepine Use in the United States.
Ladapo JA; Larochelle MR; Chen A; Villalon MM; Vassar S; Huang DYC; Mafi JN
JAMA Psychiatry; 2018 Jun; 75(6):623-630. PubMed ID: 29710086
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
